Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed Nov 8, 2022 · 10-Q · 39 days after period end · 0000950170-22-023160
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$51.09M | -$36.66M | -$34.11M | -$68.11M |
| EPS Diluted | -$1.32 | -$0.98 | -$1.02 | -$9.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 8, 2022 · 39 d after period end
